数据驱动方法优化分化型甲状腺癌预后预测:一项前瞻性多中心研究
该研究基于意大利甲状腺癌观察数据库的前瞻性队列,纳入4773例分化型甲状腺癌患者,中位随访26个月,构建决策树模型预测持续/复发疾病。模型将高危分类对结构性疾病敏感性从37%提高至49%,低危患者阴性预测值提高3%。年龄、体重指数、肿瘤大小、性别、甲状腺癌家族史、手术方式、术前细胞学及诊断情形等变量显著影响预测。
要点
- 决策树模型较2015美国甲状腺协会(ATA)危险分层系统提高高危分类敏感性(37%→49%)和低危阴性预测值(提高3%)。
- 年龄、体重指数、肿瘤大小、性别、甲状腺癌家族史、手术方式、术前细胞学及诊断情形显著影响持续/复发预测。
- 当前危险分层系统可通过纳入其他变量来补充,以改善治疗反应预测。
核心结论
- 当前危险分层系统可能通过纳入其他变量来补充,以改善治疗反应预测。
- 完整数据集有助于更精确的患者聚类。
研究设计与样本
- 前瞻性队列研究,使用意大利甲状腺癌观察数据库(NCT04031339),纳入40个意大利临床中心的连续分化型甲状腺癌患者,至少具有早期随访数据(n=4773;中位随访26个月;四分位距12-46个月)。
- 构建决策树为每例患者分配风险指数,并评估不同变量对风险预测的影响。
主要发现
- 按ATA风险估计,2492例(52.2%)为低危,1873例(39.2%)为中危,408例为高危。
- 决策树模型优于ATA风险分层系统:高危分类对结构性疾病敏感性从37%提高至49%,低危患者阴性预测值提高3%。
- 年龄、体重指数、肿瘤大小、性别、甲状腺癌家族史、手术方式、术前细胞学及诊断情形等未纳入ATA系统的变量显著影响疾病持续/复发预测。
关键数值与推荐
- ATA风险估计:低危2492例(52.2%),中危1873例(39.2%),高危408例。
- 决策树模型:高危分类对结构性疾病敏感性从37%提高至49%;低危患者阴性预测值提高3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in clinical decision making. The most widely accepted method to assess risk of recurrent/persistent disease is described in the 2015 American Thyroid Association (ATA) guidelines. However, recent research has focused on the inclusion of novel features or questioned the relevance of currently included features. OBJECTIVE: To develop a comprehensive data-driven model to predict persistent/recurrent disease that can capture all available features and determine the weight of predictors. METHODS: In a prospective cohort study, using the Italian Thyroid Cancer Observatory (ITCO) database (NCT04031339), we selected consecutive cases with DTC and at least early follow-up data (n = 4773; median follow-up 26 months; interquartile range, 12-46 months) at 40 Italian clinical centers. A decision tree was built to assign a risk index to each patient. The model allowed us to investigate the impact of different variables in risk prediction. RESULTS: By ATA risk estimation, 2492 patients (52.2%) were classified as low, 1873 (39.2%) as intermediate, and 408 as high risk. The decision tree model outperformed the ATA risk stratification system: the sensitivity of high-risk classification for structural disease increased from 37% to 49%, and the negative predictive value for low-risk patients increased by 3%. Feature importance was estimated. Several variables not included in the ATA system significantly impacted the prediction of disease persistence/recurrence: age, body mass index, tumor size, sex, family history of thyroid cancer, surgical approach, presurgical cytology, and circumstances of the diagnosis. CONCLUSION: Current risk stratification systems may be complemented by the inclusion of other variables in order to improve the prediction of treatment response. A complete dataset allows for more precise patient clustering.
引用
- Grani G, Gentili M, Siciliano F, et al. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study. J Clin Endocrinol Metab. 2023. PMID: 36795619. doi:10.1210/clinem/dgad075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。